These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6859835)

  • 1. In vitro activity of rifampin in combination with oxacillin against Staphylococcus aureus.
    Maduri Traczewski M; Goldmann DA; Murphy P
    Antimicrob Agents Chemother; 1983 Apr; 23(4):571-6. PubMed ID: 6859835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of penicillin and rifampin against group B streptococci.
    Maduri-Traczewski M; Szymczak EG; Goldmann DA
    Rev Infect Dis; 1983; 5 Suppl 3():S586-92. PubMed ID: 6356281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Killing rate and serum bactericidal activity of oxacillin, rifampin and ciprofloxacin against Staphylococcus aureus.
    Moretti MV; Fiorio M; Pasticci MB; Moretti A; Baldelli F; Pauluzzi S
    Microbiologica; 1989 Oct; 12(4):297-306. PubMed ID: 2586332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of novobiocin and rifampin alone and in combination against oxacillin-resistant Staphylococcus aureus.
    Johnston BL; Kwok RY; Mulligan ME
    Diagn Microbiol Infect Dis; 1987 Nov; 8(3):137-47. PubMed ID: 3440369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of clindamycin in combination with oxacillin, rifampin, or vancomycin against Staphylococcus aureus.
    Ho JL; Klempner MS
    Diagn Microbiol Infect Dis; 1986 Feb; 4(2):133-8. PubMed ID: 3956136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro study of the combination of rifampin with oxacillin against Staphylococcus aureus.
    Van der Auwera P; Klastersky J
    Rev Infect Dis; 1983; 5 Suppl 3():S509-14. PubMed ID: 6635442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus.
    Bayer AS; Morrison JO
    Antimicrob Agents Chemother; 1984 Aug; 26(2):220-3. PubMed ID: 6567464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synergistic effect of PDT and oxacillin on clinical isolates of Staphylococcus aureus.
    Iluz N; Maor Y; Keller N; Malik Z
    Lasers Surg Med; 2018 Jul; 50(5):535-551. PubMed ID: 29333608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bactericidal activity of oxacillin against beta-lactamase-hyperproducing Staphylococcus aureus.
    Woods GL; Yam P
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1614-8. PubMed ID: 3266987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus.
    Rand KH; Houck HJ
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2871-5. PubMed ID: 15273094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rifampin and oxacillin on the ultrastructure and growth of Staphylococcus aureus.
    Lorian V; Atkinson B; Kim Y
    Rev Infect Dis; 1983; 5 Suppl 3():S418-27. PubMed ID: 6556709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism between nafcillin or oxacillin and rifampin against Staphylococcus aureus.
    Watanakunakorn C; Tisone JC
    Antimicrob Agents Chemother; 1982 Nov; 22(5):920-2. PubMed ID: 7181497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin].
    Kotulová D; Slobodníková L
    Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antistaphylococcal activity of amoxicillin and ticarcillin when combined with clavulanic acid. Evaluation of oxacillin-resistant and oxacillin-susceptible isolates.
    Barry AL
    Diagn Microbiol Infect Dis; 1990; 13(5):357-61. PubMed ID: 2282775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antistaphylococcal activity of rifampin with other antibiotics.
    Zinner SH; Lagast H; Klastersky J
    J Infect Dis; 1981 Oct; 144(4):365-71. PubMed ID: 6270215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect of quinolones and oxacillin on methicillin-resistant Staphylococcus species.
    Rohner P; Herter C; Auckenthaler R; Pechère JC; Waldvogel FA; Lew DP
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2037-41. PubMed ID: 2619272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus.
    Drugeon HB; Caillon J; Juvin ME
    J Antimicrob Chemother; 1994 Dec; 34(6):899-907. PubMed ID: 7730233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of ciprofloxacin and rifampin alone and in combination against growing and nongrowing strains of methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
    Bahl D; Miller DA; Leviton I; Gialanella P; Wolin MJ; Liu W; Perkins R; Miller MH
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1293-7. PubMed ID: 9174186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of oxacillin-resistant staphylococcal strains with hypertonic broth diluent for microdilution panels.
    Dillon LK; Howe SE
    J Clin Microbiol; 1984 Apr; 19(4):473-6. PubMed ID: 6562124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unpredictable effects of rifampin as an adjunctive agent in elimination of rifampin-susceptible and -resistant Staphylococcus aureus strains grown in biofilms.
    Croes S; Beisser PS; Neef C; Bruggeman CA; Stobberingh EE
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3907-12. PubMed ID: 20606067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.